Solana Beach, CA – According to filings with the U.S. Securities and Exchange Commission, Design Therapeutics is raising $45,500,246.00 in new funding. Sources indicate as part of senior management Chief Business Officer, Sean Jeffries played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Design Therapeutics

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company’s lead program is focused on the treatment of Friedreich’s ataxia and discovery efforts are ongoing in other degenerative diseases.

To learn more about Design Therapeutics, visit http://www.designtx.com/

Contact:
Sean Jeffries, Chief Business Officer
858-333-7250
https://www.linkedin.com/in/seanjeffries/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved